Bank of Nova Scotia’s iShares Biotechnology ETF IBB Stock Holding History

Bank of Nova Scotia’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,125	Closed	-$703K	–	1033
2024 Q2	$703K	Buy	5,125 +2,770	+118%	+$370K	﹤0.01%	811
2024 Q1	$324K	Sell	2,355 -90	-4%	-$12.3K	﹤0.01%	916
2023 Q4	$332K	Hold	2,445	–	–	﹤0.01%	931
2023 Q3	$299K	Sell	2,445 -10	-0.4%	-$1.27K	﹤0.01%	910
2023 Q2	$312K	Sell	2,455 -20	-0.8%	-$2.6K	﹤0.01%	901
2023 Q1	$320K	Sell	2,475 -400,465	-99%	-$52.4M	﹤0.01%	955
2022 Q4	$52.9M	Buy	402,940 +400,000	+13,605%	+$51.7M	0.14%	124
2022 Q3	$344K	Sell	2,940 -2,169	-42%	-$269K	﹤0.01%	1026
2022 Q2	$601K	Hold	5,109	–	–	﹤0.01%	985
2022 Q1	$666K	Sell	5,109 -14,800	-74%	-$1.93M	﹤0.01%	1001
2021 Q4	$3.04M	Hold	19,909	–	–	﹤0.01%	814
2021 Q3	$3.22M	Sell	19,909 -482,260	-96%	-$81.2M	0.01%	745
2021 Q2	$82.2M	Buy	502,169 +500,000	+23,052%	+$77M	0.15%	127
2021 Q1	$327K	Sell	2,169 -1,000,000	-100%	-$159M	﹤0.01%	1004
2020 Q4	$152M	Buy	1,002,169 +999,998	+46,062%	+$143M	0.32%	79
2020 Q3	$294K	Buy	2,171 +2	+0.1%	+$271	﹤0.01%	954
2020 Q2	$296K	Sell	2,169 -13,663	-86%	-$1.74M	﹤0.01%	824
2020 Q1	$1.71M	Buy	15,832 +13,663	+630%	+$1.57M	0.01%	578
2019 Q4	$261K	Hold	2,169	–	–	﹤0.01%	875
2019 Q3	$216K	Sell	2,169 -14,316	-87%	-$1.5M	﹤0.01%	872
2019 Q2	$1.8M	Buy	16,485 +356	+2%	+$37.9K	0.01%	626
2019 Q1	$1.8M	Buy	16,129 +13,962	+644%	+$1.53M	0.01%	640
2018 Q4	$209K	Sell	2,167 -2	-0.1%	-$212	﹤0.01%	821
2018 Q3	$264K	Hold	2,169	–	–	﹤0.01%	823
2018 Q2	$238K	Hold	2,169	–	–	﹤0.01%	824
2018 Q1	$232K	Hold	2,169	–	–	﹤0.01%	876
2017 Q4	$232K	Sell	2,169 -4,032	-65%	-$431K	﹤0.01%	894
2017 Q3	$689K	Hold	6,201	–	–	﹤0.01%	810
2017 Q2	$643K	Hold	6,201	–	–	﹤0.01%	831
2017 Q1	$606K	Hold	6,201	–	–	﹤0.01%	800
2016 Q4	$549K	Hold	6,201	–	–	﹤0.01%	589
2016 Q3	$598K	Hold	6,201	–	–	﹤0.01%	487
2016 Q2	$532K	Hold	6,201	–	–	﹤0.01%	479
2016 Q1	$540K	Hold	6,201	–	–	﹤0.01%	461
2015 Q4	$700K	Sell	6,201 -358,680	-98%	-$38.9M	﹤0.01%	448
2015 Q3	$36.9M	Sell	364,881 -111,819	-23%	-$13.4M	0.2%	68
2015 Q2	$58.6M	Buy	476,700 +37,800	+9%	+$4.53M	0.29%	48
2015 Q1	$50.2M	Buy	438,900 +415,500	+1,776%	+$45.8M	0.22%	56
2014 Q4	$2.37M	Buy	+23,400	New	+$2.27M	0.01%	221
2014 Q2	–	Sell	-668,259	Closed	-$52.7M	–	577
2014 Q1	$52.7M	Sell	668,259 -699,741	-51%	-$58.3M	0.22%	61
2013 Q4	$104M	Buy	1,368,000 +969,000	+243%	+$68.7M	0.44%	33
2013 Q3	$27.9M	Sell	399,000 -992,400	-71%	-$65M	0.14%	76
2013 Q2	$80.6M	Buy	+1,391,400	New	+$80.4M	0.41%	35

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Bank of Nova Scotia's IBB Position: Q3 2024 in Review

Bank of Nova Scotia sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 5,125 shares — an estimated $703K sold.

Bank of Nova Scotia first reported a position in IBB in Q2 2013 and held it in 43 quarters. The position peaked at $152M in Q4 2020. 894 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

Bank of Nova Scotia reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
Bank of Nova Scotia sold 5,125 iShares Biotechnology ETF shares in Q3 2024, an estimated $703K.
Bank of Nova Scotia first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 43 quarters.
Bank of Nova Scotia's iShares Biotechnology ETF position peaked at $152M in Q4 2020.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Bank of Nova Scotia's 13F filing for Q3 2024, filed 13 Nov 2024.